28 unknown. 28 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 28 | Unknown 28 |
| Phase 2 | 8 | Unknown 8 |
Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma | Phase 3 | Unknown | Respirent Pharmaceuticals Co Ltd. | 451 | 2023-01-30 | 2023-03-01 |
| Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler - Bronchial Asthma | Phase 3 | Unknown | Glenmark Pharmaceuticals Ltd. India | 790 | 2022-04-15 | 2022-05-27 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma Doxophylline, Budesonide - Asthma Chronic, Asthma in Children | Phase 3 | Unknown | Universidad Autonoma de Nuevo Leon | 60 | 2019-05-01 | 2019-03-19 |
| A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 Test Product, Reference Product, Placebo - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 1204 | 2018-10-01 | 2018-06-20 |
| Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base Placebo, 90 mcg Reference Product, 180 mcg Reference Product - Asthma | Phase 3 | Unknown | Amneal Ireland Limited | 100 | 2018-03-16 | 2018-06-14 |
| The Effect of Benralizumab on Exercise-induced Bronchoconstriction Benralizumab - Asthma, Exercise-Induced | Phase 3 | Unknown | Louis-Philippe Boulet | 40 | 2017-12-01 | 2017-10-31 |
| Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years Fluticasone/ Formoterol, fluticasone/ salmeterol - Asthma | Phase 3 | Unknown | Mundipharma (China) Pharmaceutical Co. Ltd | 330 | 2017-06-02 | 2019-04-29 |
| Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma Salmeterol Xinafoate and Fluticasone Propinate Powder, Seretide - Asthma | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 300 | 2017-04-01 | 2018-03-12 |
| Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma GINA treatment fot asthma +vit.D low supplementation dose, GINA treatment fot asthma +vit.D high supplementation dose - Asthma | Phase 3 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 100 | 2015-11-01 | 2015-11-25 |
| Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial. Hi-dose iv MgSO4, Nebulized budesonide, Std-dose iv MgSO4 - Bronchial Asthma | Phase 3 | Unknown | Hamad Medical Corporation | 240 | 2015-06-01 | 2024-03-22 |
| IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency Immune Globulin - Asthma | Phase 3 | Unknown | Ajou University School of Medicine | 30 | 2013-12-01 | 2016-05-02 |
| Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma ALAIR, radiofrequency catheter for bronchial THERMOPLASTY - Asthma | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 46 | 2012-12-01 | 2017-11-07 |
| Effect of Aerobic Training in Moderate or Severe Asthmatic Patients Aerobic training, Breathing exercise - Asthma. | Phase 3 | Unknown | Instituto de Investigação em Imunologia | 58 | 2012-07-01 | 2014-01-10 |
| Effects of Montelukast on Airway Regulatory T Cells in Asthma Montelukast - Asthma | Phase 2 / Phase 3 | Unknown | Kurume University | 15 | 2012-06-01 | 2013-09-27 |
| Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations Mepolizumab, Placebo - Asthma, Viral Infection | Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 48 | 2012-01-01 | 2012-02-07 |
| Study for Asthma Education in Primary Schools Educational Program, Usual Asthma Information for teachers - Asthma | Phase 3 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 4506 | 2011-11-01 | 2012-06-19 |
| CPASMA: Is There an Improvement in Asthma in Patients With Both Asthma and OSAS Treated With CPAP? CPAP - Asthma, Obstructive Sleep Apnea Syndrome | Phase 3 | Unknown | Cimera | 120 | 2011-07-01 | 2012-06-22 |
Showing 20 of 28. Sign in to see all of them.
Inflammation (2) · Lymphoma, Follicular (2) · Status Asthmaticus (2) · Asthma, Exercise-Induced (1) · Bronchial Hyperreactivity (1) · Conjunctivitis, Allergic (1) · Dermatitis, Atopic (1) · Eosinophilia (1) · Food Hypersensitivity (1) · Hypersensitivity (1) · IgG Deficiency (1) · Infections (1) · Lung Diseases, Obstructive (1) · Motor Activity (1)
Bronchial Diseases (28) · Hypersensitivity, Immediate (28) · Immune System Diseases (28) · Respiratory Hypersensitivity (28) · Respiratory Tract Diseases (28) · Hypersensitivity (27) · Lung Diseases (27) · Lung Diseases, Obstructive (26) · Hemic and Lymphatic Diseases (4) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Hematologic Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2)
Budesonide (5) · Fluticasone-Salmeterol Drug Combination (4) · montelukast (4) · Fluticasone (2) · Salmeterol Xinafoate (2) · Albuterol (1) · Breathing Exercises (1) · Bronchial Thermoplasty (1) · Immunoglobulins (1) · Magnesium Sulfate (1) · Omalizumab (1) · Saline Solution (1) · benralizumab (1) · doxofylline (1) · fluticasone-formoterol (1)
Amneal Ireland Limited (2) · EMS (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ajou University School of Medicine (1) · Assistance Publique - Hôpitaux de Paris (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Cimera (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Glenmark Pharmaceuticals Ltd. India (1) · Hamad Medical Corporation (1) · Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1) · Instituto de Investigação em Imunologia (1) · King's College London (1) · Kurume University (1)
Brazil (3) · China (3) · United States (3) · India (2) · Spain (2) · United Kingdom (2) · Finland (1) · France (1) · Greece (1) · Japan (1) · Mexico (1) · Netherlands (1) · Poland (1) · Qatar (1)
Irshad Haque (2) · Alok Nath, MD (1) · Ameet Daftary (1) · Andrew Wilson, MD, MRCP (UK) (1) · Aubier Michel (1) · Christopher Corrigan, MD, PhD (1) · Elisabeth H Bel, MD, PhD (1) · Emmanuelle Dexeus Gabriel Fernandez, pediatrician (1) · Erkki Savilahti, Professor (1) · Iwona Stelmach, Prof. (1) · Jeffrey Blumer, MD (1) · Jeffrey L. Blumer, M.D., Ph.D. (1) · Jose Serrano, MD (1)
PMID 36472162, PMID 17356056, PMID 18595980, PMID 19535666, PMID 19726699, PMID 19797480, PMID 19817753, PMID 20420722, PMID 20525652, PMID 20526242, PMID 20538327, PMID 20620566, PMID 20870246, PMID 21315433, PMID 21771118, PMID 21986034, PMID 22093109, PMID 22330698, PMID 22532985, PMID 23595876, PMID 23792089, PMID 24067388, PMID 24447429, PMID 24506910, PMID 24650447, PMID 24698320, PMID 24838406, PMID 24989842, PMID 25277142, PMID 25631639, PMID 25640020, PMID 25643669, PMID 25724847, PMID 25732539, PMID 25749414, PMID 25845986, PMID 25899478, PMID 26019776, PMID 26063507, PMID 27824606, PMID 28298402, PMID 28318759, PMID 29031617, PMID 30326954, PMID 30472801, PMID 34857814, PMID 37438187, PMID 38687061, PMID 42605209, PMID 9727780
2009 (1)